Other
Abdominal Surgery
0
Pipeline Programs↗
10
Active Trials↗
6
Companies Involved↗
Abdominal Surgery is an early-stage landscape with 0 programs across 6 companies. The most active players are EKR Therapeutics, Inc, Beijing Tide Pharmaceutical Co., Ltd, Cara Therapeutics, Inc..
Intelligence
Pipeline Metrics
Competitive Density
Pipeline Velocity
Mech. Concentration
Completion Rate
Attrition Rate
Competition
Competitive Landscape
Bubble size = clinical trials
Approved
Phase 3
Phase 2
Phase 1
Preclinical
Key Players
Top Companies Companies ranked by the number of pipeline programs they run for this disease.
Pipeline
Programs by Phase
No pipeline programs currently tracked for this disease.
Analysis
Trial Status
49
clinical trials
Completed29 · 59%
Unknown status8 · 16%
Recruiting4 · 8%
Not yet recruiting3 · 6%
Active, not recruiting3 · 6%
Terminated2 · 4%
Clinical Trials
Trial Activity
49 trials
Tranexamic Acid for Reduction of Transfusion in Abdominal Surgery
Recruiting·—·Phase 3·NCT06414031·850 enrolled
Effect of Magnesium Sulphate Pretreatment in Pediatric Abdominal Surgery
Recruiting·—·Phase 2/3·NCT05736744·58 enrolled
External Oblique Intercostal Plane Block for Postoperative Analgesia After Major Upper Abdominal Surgery: A Randomized Controlled Trial
Recruiting·—·Preclinical·NCT07331441·78 enrolled
Dalargin for Prevention of Organ Disfunction in High-Risk Abdominal Surgery
Active, not recruiting·—·Phase 3·NCT07404358·200 enrolled
Effect of Acupuncture and Herbal Medicine on Bowel Recovery After Abdominal Surgery
Not yet recruiting·GGuang'anmen Hospital of China Academy of Chinese Medical Sciences·N/A·NCT07081802·148 enrolled
NON-INVASIVE RESPIRATORY MONITORING TO PREDICT A SEPARATION FROM MECHANICAL VENTILATION IN PATIENTS WITH UPPER ABDOMINAL SURGERY: THE VALUE STUDY - PREVALENCE, PREDICTIVE AND PRAGMATICAL STUDY
Not yet recruiting·—·N/A·NCT07678502·40 enrolled
Effect of Prostacyclin on Haemostasis in Abdominal Surgery
Completed·—·Phase 1·NCT01528943·40 enrolled
Page 1 of 4
Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)